| 翻訳と辞書 |
Nasal EPAP
Nasal EPAP (Expiratory Positive Airway Pressure) is a treatment for snoring and obstructive sleep apnea (OSA). Nasal EPAP utilizes the user’s own breathing to create positive airway pressure to prevent obstructed breathing. The first commercially available nasal EPAP device indicated for the treatment of obstructive sleep apnea (Provent Therapy) was cleared by the United States FDA in 2008. To treat snoring, over-the-counter devices like Theravent are now available using the same nasal EPAP technology. In a series of published articles, nasal EPAP has been shown to provide statistically significant reductions in apnea hypopnea index (AHI), oxygen desaturation index (ODI) and sleepiness, with high patient acceptance and compliance. It has also been proven, through clinical tests, to reduce snoring by 76%.〔A Novel Non-Prescription Nasal EPAP Device (Theravent) to Treat Snoring by Rajiv Doshi, MD and Philip Westrbook, MD〕〔Patel AV, Hwang D, Masdeu MJ et al. Predictors of response to a nasal expiratory resistor device and its potential mechanisms of action for treatment of obstructive sleep apnea. J Clin Sleep Med 2011;7:13-22.〕〔Colrain I, Turlington S. The use of a nasal resistance valve to treat sleep disordered breathing. SLEEP Abstract Supplement. 2008;31: A172.〕〔CW Braga, Q Chen, O Burschtin, et al. Imaging of FRC and upper airway dimensions by MRI during application of nEPAP in patients with SDB, 12th International Symposium, Sleep and Breathing, Barcelona, Spain April 2011.〕〔Berry RB, Kryger MH, Massie CA. A novel nasal expiratory positive airway pressure device for the treatment of obstructive sleep apnea: a randomized controlled trial. SLEEP 2011;34:479-485.〕〔Walsh JK, Griffin KS, Forst EH, et al. A convenient expiratory positive airway pressure nasal device for the treatment of sleep apnea in patients non-adherent with continuous positive airway pressure. Sleep Med 2011;12:147-52.〕〔Rosenthal L, Massie CA, Dolan DC, et al. A multicenter, prospective study of a novel nasal EPAP device in the treatment of obstructive sleep apnea. Efficacy and 30-day adherence. J Clin Sleep Med 2009;5:532-37.〕〔Colrain IM, Brooks S, Black J. A pilot evaluation of a nasal expiratory resistance device for the treatment of obstructive sleep apnea. J Clin Sleep Med 2008;4:426-33.〕〔Kryger MH, Berry RB, Massie CA. Long term use of a nasal expiratory positive airway pressure (EPAP) device as a treatment for obstructive sleep apnea. J Clin Sleep Med 2011:7:5:449-453.〕〔Adams, G, Retrospective cases series analysis of a nasal expiratory positive airway pressure (EPAP) device to treat obstructive sleep apnea in a clinical practice, SLEEP Abstract Supplement, 2011 (34):A146.〕〔Hwang D, Becker K, Chang J et al.Nasal EPAP as a major therapeutic option in a clinical sleep center setting, SLEEP Abstract Supplement, 2011 (34):A146.〕〔Massie C, Hart RW. Clinical efficacy of a nasal expiratory positive airway pressure (EPAP) device for the treatment of obstructive sleep apnea, SLEEP Abstract Supplement, 2011 (34):A146.〕
==Background==
抄文引用元・出典: フリー百科事典『 ウィキペディア（Wikipedia）』
■ウィキペディアで「Nasal EPAP」の詳細全文を読む
スポンサード リンク
| 翻訳と辞書 : 翻訳のためのインターネットリソース |
Copyright(C) kotoba.ne.jp 1997-2016. All Rights Reserved.
|
|